VERGANI, ELISABETTA
VERGANI, ELISABETTA
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.003 secondi).
BRAF AND MAPK PATHWAY MOLECULES FOR TARGETED THERAPY OF MALIGNANT MELANOMA
2012 E. Vergani
Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction
2020 J. Gliozzo, P. Perlasca, M. Mesiti, E. Casiraghi, V. Vallacchi, E. Vergani, M. Frasca, G. Grossi, A. Petrini, M. Re, A. Paccanaro, G. Valentini
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30+ T lymphocytes with progression
2014 V. Vallacchi, E. Vergani, C. Camisaschi, P. Deho, A.D. Cabras, M. Sensi, L. De Cecco, N. Bassani, F. Ambrogi, A. Carbone, F. Crippa, B. Vergani, P. Frati, F. Arienti, R. Patuzzo, A. Villa, E. Biganzoli, S. Canevari, M. Santinami, C. Castelli, L. Rivoltini, M. Rodolfo
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| BRAF AND MAPK PATHWAY MOLECULES FOR TARGETED THERAPY OF MALIGNANT MELANOMA | 20-apr-2012 | E. Vergani | Doctoral Thesis | - | |
| Network modeling of patients' biomolecular profiles for clinical phenotype/outcome prediction | 1-gen-2020 | Perlasca P.Mesiti M.Casiraghi E.Vergani E.Frasca M.Grossi G.Petrini A.Re M.Valentini G. + | Article (author) | - | |
| Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30+ T lymphocytes with progression | 1-gen-2014 | E. VerganiC. CamisaschiA.D. CabrasN. BassaniF. AmbrogiB. VerganiE. Biganzoli + | Article (author) | - |